{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:56:12Z","timestamp":1792371372463,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00259-016-3421-6","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T22:12:33Z","timestamp":1465769553000},"page":"2014-2020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Potential role of 68Ga-DOTATOC PET\/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Vikas","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Tiling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Pl\u00f6ckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"3421_CR1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. Von Hippel-Lindau disease. Lancet. 2003;361:2059\u201367.","journal-title":"Lancet"},{"key":"3421_CR2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S. Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19:617\u201323.","journal-title":"Eur J Hum Genet"},{"key":"3421_CR3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317\u201320.","journal-title":"Science"},{"issue":"1","key":"3421_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","volume":"68","author":"JM Lamiell","year":"1989","unstructured":"Lamiell JM, Salazar FG, Hsia YE. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989;68(1):1\u201329.","journal-title":"Medicine (Baltimore)"},{"issue":"8749","key":"3421_CR5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","volume":"337","author":"HP Neumann","year":"1991","unstructured":"Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991;337(8749):1052\u20134.","journal-title":"Lancet"},{"issue":"4","key":"3421_CR6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s003300050717","volume":"9","author":"FJ Hes","year":"1999","unstructured":"Hes FJ, Feldberg MA. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses). Eur Radiol. 1999;9(4):598\u2013610.","journal-title":"Eur Radiol"},{"issue":"4","key":"3421_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","volume":"119","author":"PR Hammel","year":"2000","unstructured":"Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d\u2019Etude de la Maladie de von Hippel-Lindau. Gastroenterology. 2000;119(4):1087\u201395.","journal-title":"Gastroenterology"},{"issue":"6","key":"3421_CR8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","volume":"142","author":"JA Blansfield","year":"2007","unstructured":"Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 2007;142(6):814\u20138.","journal-title":"Surgery"},{"issue":"1","key":"3421_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/RCT.0b013e3181b52b84","volume":"34","author":"C Neuzillet","year":"2010","unstructured":"Neuzillet C, Vullierme MP, Couvelard A, Sauvanet A, Levy P, Richard S, et al. Difficult diagnosis of atypical cystic pancreatic lesions in von Hippel-Lindau disease. J Comput Assist Tomogr. 2010;34(1):140\u20135.","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"3421_CR10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EJE-15-1012","volume":"174","author":"SJ Asselt van","year":"2016","unstructured":"van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Koopmans KP, et al. Potential value of EUS in pancreatic surveillance of VHL patients. Eur J Endocrinol. 2016;174(5):611\u201320.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"3421_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.2253011297","volume":"225","author":"HB Marcos","year":"2002","unstructured":"Marcos HB, Libutti SK, Alexander HR, Lubensky IA, Bartlett DL, Walther MM, et al. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology. 2002;225(3):751\u20138.","journal-title":"Radiology"},{"issue":"6","key":"3421_CR12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.surg.2011.09.048","volume":"150","author":"M Kitano","year":"2011","unstructured":"Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, et al. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery. 2011;150(6):1122\u20138.","journal-title":"Surgery"},{"issue":"6","key":"3421_CR13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.6004\/jnccn.2012.0075","volume":"10","author":"MH Kulke","year":"2012","unstructured":"Kulke MH, Benson 3rd AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, et al. Neuroendocrine tumors. J Natl Compr Cancer Netw. 2012;10(6):724\u201364.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"3421_CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology. 2016;103(2):172\u201385.","journal-title":"Neuroendocrinology"},{"key":"3421_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-540-31203-1_18","volume":"170","author":"RP Baum","year":"2008","unstructured":"Baum RP, Prasad V, Hommann M, H\u00f6rsch D. Receptor PET\/CT imaging of neuroendocrine tumors. Recent Results Cancer Res. 2008;170:225\u201342.","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"3421_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-011-1935-5","volume":"39","author":"NF Schreiter","year":"2012","unstructured":"Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape UF, et al. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET\/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39(1):72\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3421_CR17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","volume":"48","author":"KP Zhernosekov","year":"2007","unstructured":"Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med. 2007;48(10):1741\u20138.","journal-title":"J Nucl Med"},{"issue":"10","key":"3421_CR18","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","volume":"37","author":"I Virgolini","year":"2010","unstructured":"Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37(10):2004\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"3421_CR19","first-page":"471","volume":"48","author":"S Surti","year":"2007","unstructured":"Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007;48(3):471\u201380.","journal-title":"J Nucl Med"},{"issue":"2","key":"3421_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103(2):153\u201371.","journal-title":"Neuroendocrinology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3421-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3421-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:14:58Z","timestamp":1498306498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3421-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3421"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3421-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}